Literature DB >> 12149265

CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required.

Qianghua Hu1, Chitralekha Bhattacharya, Sankar N Maity.   

Abstract

To understand the role of the CCAAT binding factor (CBF) in transcription during the cell cycle, we studied the mouse topoisomerase II alpha (topo II alpha) promoter, which is activated during the late S and G(2)/M phases of the cell cycle and contains multiple CBF binding sites. Mutational analysis of the promoter shows that CBF binding to an inverted orientation of the CCAAT motif in the topo II alpha promoter, but not to a direct orientation, is required for transcription activation during the cell cycle. In contrast, analysis of the promoter in an in vitro reconstituted transcription system shows that CBF activates transcription of the topo II alpha promoter irrespective of the orientation of the CBF binding sites. This analysis demonstrates that only one of the three transcription start sites of the topo II alpha promoter is stimulated by CBF, indicating that transcription activation by CBF is dependent on basal promoter structure. Interestingly, mutations of the start site that abolish CBF-dependent transcription activation in vitro do not inhibit activation of the promoter during the cell cycle. Consistent with this observation, expression of a truncated CBF-B subunit lacking a transcription activation domain, which inhibits activity of a collagen promoter, does not affect activity of the topo II alpha promoter in fibroblast cells. In contrast, expression of an allele-specific CBF-B mutant that binds high affinity to a mutant CBF binding site containing a CCAAC motif revives transcription activation of an inactive mutant topo II alpha promoter containing CCAAC during the cell cycle. Altogether, this study indicates that CBF binding, but not conventional CBF activation domains, are required for activation of the topo II alpha promoter during the cell cycle. Considering these results together with results of another recent study, we hypothesize that binding of CBF that disrupts the nucleosomal structure in the topo II alpha promoter is a major function of CBF by which it regulates the cell cycle-dependent transcription of the topo II alpha promoter and possibly many other cell cycle-regulated promoters containing CBF binding sites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149265     DOI: 10.1074/jbc.M205985200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Nuclear transcription factor Y and its roles in cellular processes related to human disease.

Authors:  Luong Linh Ly; Hideki Yoshida; Masamitsu Yamaguchi
Journal:  Am J Cancer Res       Date:  2013-08-14       Impact factor: 6.166

2.  The new core promoter element XCPE1 (X Core Promoter Element 1) directs activator-, mediator-, and TATA-binding protein-dependent but TFIID-independent RNA polymerase II transcription from TATA-less promoters.

Authors:  Yumiko Tokusumi; Ying Ma; Xianzhou Song; Raymond H Jacobson; Shinako Takada
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

3.  Type II topoisomerase activities in both the G1 and G2/M phases of the dinoflagellate cell cycle.

Authors:  Carmen K M Mak; Victor K L Hung; Joseph T Y Wong
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

4.  Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro.

Authors:  Chandrani Chattopadhyay; David Hawke; Ryuji Kobayashi; Sankar N Maity
Journal:  Nucleic Acids Res       Date:  2004-07-08       Impact factor: 16.971

5.  CCAAT-binding factor regulates expression of the beta1 subunit of soluble guanylyl cyclase gene in the BE2 human neuroblastoma cell line.

Authors:  Iraida G Sharina; Emil Martin; Anthony Thomas; Karen L Uray; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

6.  NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells.

Authors:  Azat Garipov; Hua Li; Benjamin G Bitler; Roshan J Thapa; Siddharth Balachandran; Rugang Zhang
Journal:  Mol Cancer Res       Date:  2013-01-29       Impact factor: 5.852

7.  Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells.

Authors:  Nancy E Castro; Mitsuo Kato; Jung Tak Park; Rama Natarajan
Journal:  J Biol Chem       Date:  2014-09-09       Impact factor: 5.157

8.  Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle.

Authors:  Qianghua Hu; Jing-Fang Lu; Rong Luo; Subrata Sen; Sankar N Maity
Journal:  Nucleic Acids Res       Date:  2006-11-10       Impact factor: 16.971

9.  Transcription factor NF-Y is involved in differentiation of R7 photoreceptor cell in Drosophila.

Authors:  Yasuhide Yoshioka; Luong Linh Ly; Masamitsu Yamaguchi
Journal:  Biol Open       Date:  2011-10-24       Impact factor: 2.422

10.  Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor.

Authors:  Martín L Marro; Concepción Peiró; Catherine M Panayiotou; Reshma S Baliga; Sabine Meurer; Harald H H W Schmidt; Adrian J Hobbs
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.